Full-Time

Pharmacist

Posted on 10/31/2025

Deadline 9/23/26
BrightSpring Health Services

BrightSpring Health Services

10,001+ employees

Home-based and community health services, pharmacy

Compensation Overview

$55 - $65/hr

+ Competitive Pay

San Antonio, TX, USA

In Person

Category
Medical, Clinical & Veterinary (3)
, ,
Requirements
  • Bachelor of Science in Pharmacy required; Doctor of Pharmacy preferred
  • Registered Pharmacist License in state(s) of practice
  • Minimum of two (2) years of recent experience in an acute-care setting or one (1) year of recent experience in home infusion therapy
  • Experience with compounding infused drugs
  • Proven record of evaluating and monitoring drug therapies for home care patients
  • Good organizational and time-management skills
  • Participation and membership in professional societies and organizations is desirable
  • Excellent verbal and written communication skills
  • Flexible schedule with the ability to work on-call evenings and weekends on an as-scheduled basis
  • Percentage of Travel: 0-25%-Minimal travel may be required
  • To perform this role will required constant sitting and typing on a keyboard with fingers, and occasionally standing, and walking. The physical requirements will be the ability to push/pull and lift/carry 10-30 lbs
Responsibilities
  • Evaluates and monitor drug therapy relative to the total needs of the home care patient in collaboration with physicians, nurses and other healthcare professionals.
  • Adheres to organization policies and procedures and all applicable state and federal laws and regulations governing pharmacy practice.
  • Adheres to all appropriate standards of accreditationand participate in quality assurance activities.
  • Coordinates and facilitate new referrals and admissions through collaboration with nurses, customer service and distribution.
  • Reviews, receives and verifies all new patient orders and document on the respective order form.
  • Assists the physician and other involved healthcare professionals with: Planning and implementing patient care in the home; Setting therapeutic objectives for drug therapy; Establishing parameters for monitoring the safety and efficacy of drug therapy; and Preparting regular progress reports.
  • Conducts and document initial and ongoing assessment of specific patient, drug and disease information to identify real and potential drug-related problems or needs.
  • Monitors the outcomes of drug therapy by collecting, evaluating and interpreting the results of laboratory data, clinical data and other pertinent patient information.
  • Provides consultation and answer inquiries from patients, families, physicians and other healthcare professionals regarding drugs and their use.
  • Maintains thorough and appropriate documentation in the customer/patient record of all clinical activities and communication with patients, physicians and other healthcare professionals.
  • Processes and check all medications, supplies and equipment prior to dispensing from the pharmacy.
  • Maintains clinical skills and knowledge of pharmacotherapy by reviewing literature and attending in-services, seminars and conferences
  • Compounds sterile mixtures and non-mixtures, including, but not limited to parenteral nutrition, antibiotics, chemotherapy, hydration and narcotic analgesics, using aseptic technique where state laws permit
  • Ensures compounding/clean room areas and related equipment are cleaned, sanitized and maintained in compliance with company policies and procedures, and USP 797 and USP 800 standards
  • Documents all activities on appropriate logs.
  • Maintains clinical skills and knowledge of pharmacotherapy by reviewing literature and attending in-services, seminars and conferences
  • Pharmacists’ duties are extended to include overseeing of the Pharmacy technician functions as required by Pharmacy Board rules
Desired Qualifications
  • Participation and membership in professional societies and organizations is desirable
BrightSpring Health Services

BrightSpring Health Services

View

BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.

Company Size

10,001+

Company Stage

Post IPO Equity

Headquarters

Louisville, Kentucky

Founded

1974

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $3.61B, up 26%, raising full-year guidance to $14.98B.
  • Amedisys and LHC acquisitions add 107 locations, contributing $30M EBITDA in 2026.
  • Sevita sale yields $811M cash for debt reduction and $2B M&A through 2028.

What critics are saying

  • Money Message ransomware stole 2M records including SSNs in March 2023 breach.
  • DOJ fined ResCare in October 2019 for fake Medicaid revaluations from 2009-2014.
  • Pomerantz investigates securities fraud by BrightSpring officers as of 2026.

What makes BrightSpring Health Services unique

  • BrightSpring integrates specialty pharmacy with home health for complex chronic care patients.
  • PharMerica dispenses 40 million prescriptions annually to 4 million patients.
  • Provider services target intellectual disabilities via home-based behavioral health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Company News

Yahoo Finance
Apr 10th, 2026
BrightSpring Health shares jump 5.2% on 15-20% EBITDA growth targets and AI efficiency plans

BrightSpring Health Services announced the resignation of Robert Barnes as President of ResCare Community Living on 30 March 2026, stating it was not due to any disagreement over operations or policies. The company's shares rose 5.2% following upbeat analyst reports from its investor day. Management unveiled ambitious long-term organic EBITDA growth targets of 15% to 20% annually through 2028, alongside AI-driven efficiency plans for its home and community-based care platform. The narrative projects $16.8 billion in revenue and $361.8 million in earnings by 2028, requiring 10.1% yearly revenue growth. Investors remain focused on whether BrightSpring can balance acquisition-driven expansion and technology investment whilst managing its substantial debt load and regulatory exposure.

Yahoo Finance
Mar 30th, 2026
BrightSpring Health Services stock surges 43% in 6 months, but low ROIC raises concerns

BrightSpring Health Services has seen its stock price surge 43.1% over the past six months to $42.32 per share, driven by strong quarterly results. The healthcare services company, founded in 1974, offers home health care, hospice, neuro-rehabilitation and pharmacy services. BrightSpring's revenue grew at an 18.3% compound annual growth rate over the past five years, outpacing the healthcare sector average. Analysts forecast 15% revenue growth over the next 12 months, though this represents a deceleration from its recent 20.9% annual rate. However, the company's five-year average return on invested capital of 4.9% falls below the typical cost of capital for healthcare firms, suggesting historically mediocre capital efficiency. The stock currently trades at 27.7× forward price-to-earnings ratio.

Yahoo Finance
Mar 25th, 2026
BrightSpring trades at 24.5x forward P/E despite $600M revenue headwinds

BrightSpring Health Services has raised questions about its valuation after trading at 24.5 times forward earnings following strong 2025 performance. The company reported fourth-quarter revenue of $3.55 billion, up 29.3% year-over-year, with adjusted EBITDA rising 40.7% to $184 million. For 2026, management guided revenue between $14.45 billion and $15 billion, representing 11.9% to 16.2% growth, whilst adjusted EBITDA is expected to grow faster at 23% to 28%, indicating margin expansion. However, the company faces approximately $600 million in revenue headwinds from Inflation Reduction Act impacts and brand-to-generic conversions. The valuation hinges on whether BrightSpring can deliver sequential profitability improvements throughout the year despite policy and product-mix pressures affecting headline revenue growth.

Yahoo Finance
Mar 24th, 2026
BrightSpring tops Q4 senior health earnings as Chemed's $639M revenue disappoints

BrightSpring Health Services led senior health stocks in Q4 earnings, reporting revenues of $3.55 billion, up 16.3% year on year and beating analyst expectations by 5%. The company delivered strong full-year EBITDA guidance. In contrast, Chemed posted the weakest performance, with revenues of $639.3 million falling 3% short of expectations. The company missed both revenue and full-year EPS guidance estimates, sending shares down 19.2% to $377.07. The seven senior health, home health and hospice stocks tracked reported slower Q4 results overall, with revenues beating consensus estimates by just 1.1%. Share prices have declined an average of 9.6% since earnings releases. The sector faces headwinds from labour shortages and wage inflation whilst benefiting from an ageing population and growing preference for in-home care.

Yahoo Finance
Mar 19th, 2026
BrightSpring projects sub-2x leverage in 2026, unveils $2B M&A firepower and integrated care strategy

BrightSpring Health Services outlined its growth strategy at an investor day, highlighting a shift towards core home-and-community clinical services. The company's planned community-living divestiture will close soon to boost cash flow and support integrated care initiatives. BrightSpring reported significant deleveraging from approximately 4.5x post-IPO to 2.99x (2.6x pro forma), with leverage expected to fall below 2x in 2026. The company reiterated 2026 guidance of $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA, whilst targeting 15–20% organic adjusted EBITDA compound annual growth for 2026–2028. The healthcare services provider has at least $2 billion available for acquisitions through 2028. Its operations include dispensing over 40 million prescriptions annually through PharMerica, serving more than 4 million patients, with recent branch integrations expected to add approximately $30 million of EBITDA.

INACTIVE